Medicine Description neupgen 0.48mg
Neupgen 0.48mg Ampoules is a medication that contains filgrastim, a recombinant form of human granulocyte colony-stimulating factor (G-CSF). This biologically active protein stimulates the bone marrow to increase the production and maturation of neutrophils, a type of white blood cell crucial for fighting infections. Filgrastim binds to specific receptors on hematopoietic cells in the bone marrow, triggering a cascade of biological processes that enhance the proliferation and differentiation of progenitor cells into functional neutrophils. Additionally, filgrastim improves the survival of these cells by reducing apoptosis, thus leading to a higher absolute neutrophil count (ANC) in the bloodstream. This action is particularly beneficial in patients undergoing chemotherapy, as it counteracts chemotherapy-induced neutropenia, thereby reducing the incidence and duration of infections.
Indications and Uses of Neupgen 0.48mg Ampoules
- Supportive treatment for patients undergoing chemotherapy to prevent severe neutropenia
- Management of congenital neutropenia in patients with a genetic predisposition
- Enhancement of peripheral blood stem cell mobilization for transplant procedures
- Support for patients with HIV/AIDS who are experiencing neutropenia due to their condition or treatment
Side Effects of Neupgen 0.48mg Ampoules
- Bone pain or discomfort
- Injection site reactions such as redness, swelling, or pain
- Fever or chills
- Fatigue
- Headache
- Rash
- Increased levels of uric acid in the blood
Storage and Handling
Store Neupgen 0.48mg Ampoules in a refrigerator at temperatures between 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Once removed from the refrigerator, it may be kept at room temperature for up to 24 hours, but should not be returned to refrigeration.
Patient Advice and Precautions
Before administration, allow the ampoule to reach room temperature. Monitor for signs of allergic reactions, particularly after the first dose. Patients should be informed about the potential for bone pain and should consult their healthcare provider if side effects persist or worsen. Regular blood tests may be necessary to monitor neutrophil levels, and patients should be advised to report any signs of infection promptly.